3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
14
Terminated
2
Recruiting
2
Unknown
1
Sponsor Class
OTHER
9
NIH
3
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
13
Leukemia, Myeloid, Acute
12
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
9
Rectal Neoplasms
8
Prostatic Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms
6
Head and Neck Neoplasms
6
Fallopian Tube Neoplasms
6
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leukemia
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Vulvar Neoplasms
3
Urinary Bladder Neoplasms
3
Recurrence
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Liver Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Fatigue
3
Depression
3
Central Nervous System Neoplasms
3
Carcinoma, Hepatocellular
3
Stress Disorders, Post-Traumatic
2
Small Cell Lung Carcinoma
2
Interventions
pomalidomide
1
isatuximab
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
NETWORK
×
Immunoglobulin Light-chain Amyloidosis
×
Clear all
NCT05066607
2024-03-06
IsAMYP
Intergroupe Francophone du Myelome
Phase 2
Unknown
46 enrolled